Related Experiment Video
Updated: May 24, 2026

Assessment of Memory Function in Pilocarpine-induced Epileptic Mice
Published on: June 4, 2020
Pisa syndrome secondary to rivastigmine: a case report
M Leelavathi1, R Rosdinom, M Suguna
1Department of Family Medicine, Faculty of Medicine, Universiti Kebangsaan Malaysia Medical Center, Kuala Lumpur, Malaysia. drleelaraj@yahoo.com
Abstract:
Pisa syndrome or pleurothotonus is the persistent flexion of the body and head to one side giving the appearance of the leaning tower of Pisa. It is most commonly caused by typical and atypical antipsychotic drugs. We report a case of Pisa Syndrome caused by prolonged use of high dose cholinesterase inhibitor, rivastigmine. Symptoms subsided when rivastigmine was withdrawn and did not reappear when a different cholinesterase inhibitor, donepezil was introduced. Physicians should be aware of Pisa syndrome and should alert patient of this possibility when starting and stepping up medications. The purpose of reporting this case is to create awareness among general practitioners as it is a reversible condition which responds to removal of the offending drug.
Related Concept Videos
Alterations in Muscle Tone lll
Myasthenia Gravis ll: Pathophysiology
Parkinson Disease l: Introduction
Parkinson Disease ll: Pathophysiology
Multiple Sclerosis l: Introduction
Myasthenia Gravis: Diagnostic Tests
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
